カテゴリ： MarketLine, アイルランド, 企業調査

Accenture plc：企業の戦略・SWOT・財務情報

◆英語タイトル：Accenture plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C9104
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：89
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アイルランド
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Accenture plc – Strategy, SWOT and Corporate Finance Report
Summary

Accenture plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Accenture plc (Accenture or “the company”) is one of the leading professional services companies, offering management consulting, technology and outsourcing services to clients across a broad range of industries. The company operates in the Americas, Europe, Middle East and Africa (EMEA), and Asia-Pacific. It is headquartered in Dublin, Ireland.

Scope

- Detailed information on Accenture plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Accenture plc in the form of a SWOT analysis
- An in-depth view of the business model of Accenture plc including a breakdown and examination of key business segments
- Intelligence on Accenture plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Accenture plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Accenture plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Accenture plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Accenture plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Accenture plc: Company Overview 9
Accenture plc: Overview and Key Facts 9
Accenture plc: Overview 9
Accenture plc: Key Facts 9
Accenture plc: Key Employees 10
Accenture plc: Key Employee Biographies 13
Accenture plc: Major Products and Services 22
Accenture plc: Company History 24
Accenture plc: Management Statement 48
Accenture plc: Locations and Subsidiaries 53
Accenture plc: Key Competitors 55
Accenture plc: Company Analysis 56
Accenture plc: Business Description 56
Accenture plc: SWOT Analysis 59
Accenture plc: SWOT Overview 59
Accenture plc: Strengths 59
Accenture plc: Weaknesses 61
Accenture plc: Opportunities 61
Accenture plc: Threats 63
Accenture plc: Corporate Financial Deals Activity 65
Accenture plc: Financial Deals Overview 65
Accenture plc: Targets and Partners 67
Accenture plc: Top Deals 2014 – 2018YTD* 73
Accenture plc: Advisors 74
Accenture plc: Top Financial Advisors 74
Accenture plc: Mergers and Acquisitions 75
Accenture plc: Corporate Venturing 76
Accenture plc: Partnership 77
Accenture plc: Divestments 78
Accenture plc: Recent Developments 79
Accenture plc: News and Events Summary 79
Accenture plc: Business Expansion 82
Accenture plc: Contracts 83
Accenture plc: Corporate Governance 85
Accenture plc: IT Spending Announcements 85
Accenture plc: Strategy and Operations 85
Appendix 87
Contact Us 87
Methodology 87
About MarketLine 88

List of Tables
Table 1: Accenture plc: Key Facts
Table 2: Accenture plc: Key Employees
Table 3: Accenture plc: Company History
Table 4: Accenture plc: Locations and Subsidiaries
Table 5: Accenture plc: Key Competitors
Table 6: Accenture plc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Accenture plc: M&A Activity by Geography (TTM*)
Table 8: Accenture plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Accenture plc: M&A Average Deal Size - Value (US$m)
Table 10: Accenture plc: Targets and Partners
Table 11: Accenture plc: Top Deals 2014 - 2018YTD*
Table 12: Accenture plc: Financial Advisor Ranking by Value (US$m)
Table 13: Accenture plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Accenture plc: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Accenture plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Accenture plc: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Accenture plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 18: Accenture plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 19: Accenture plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 20: Accenture plc: Divestments by Geography (2014 - YTD*2018)
Table 21: Accenture plc: News and Events Summary
Table 22: Accenture plc: Business Expansion
Table 23: Accenture plc: Contracts
Table 24: Accenture plc: Corporate Governance
Table 25: Accenture plc: IT Spending Announcements
Table 26: Accenture plc: Strategy and Operations

List of Figures
Figure 1: Accenture plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Accenture plc: M&A Activity by Geography (TTM*)
Figure 3: Accenture plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Accenture plc: M&A Average Deal Size - Value (US$m)
Figure 5: Accenture plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Accenture plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Accenture plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Accenture plc: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Accenture plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Accenture plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Accenture plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 12: Accenture plc: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Accenture plc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Esterline Technologies Corporation：企業のM&A・事業提携・投資動向
    Esterline Technologies Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Esterline Technologies Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • AGL Energy Ltd (AGL)：電力：M&Aディール及び事業提携情報
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Premaitha Health Plc (NIPT)：医療機器：M&Aディール及び事業提携情報
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • nLife Therapeutics SL-製薬・医療分野：企業M&A・提携分析
    Summary nLife Therapeutics SL (nLife Therapeutics) is a biopharmaceutical company that discovers and develops proprietary neuronal specific oligonucleotides as therapeutic agents for the treatment of central nervous system disorders. Its lead candidate NLF-PD-1233 is a first in class oligonucleotide …
  • Synopsys, Inc.：企業のM&A・事業提携・投資動向
    Synopsys, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Synopsys, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Huttig Building Products Inc：企業の戦略・SWOT・財務分析
    Huttig Building Products Inc - Strategy, SWOT and Corporate Finance Report Summary Huttig Building Products Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Trumpf GmbH + Co KG：企業の戦略的SWOT分析
    Trumpf GmbH + Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • American Shared Hospital Services (AMS)：医療機器：M&Aディール及び事業提携情報
    Summary American Shared Hospital Services (ASHS) is a healthcare company that offers medical equipment to hospitals and medical centers. The company offers financial and healthcare tech solutions. Its financing solutions comprise feasibility studies and reimbursement analysis, facilities planning an …
  • The Broad Institute Inc-医療機器分野：企業M&A・提携分析
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Unit Corp (UNT)：企業の財務・戦略的SWOT分析
    Summary Unit Corp (Unit) is a diversified energy company that offers exploration and production of oil and natural gas. The company offers acquisition of producing oil and natural gas properties, contract drilling of onshore oil and natural gas wells, and gathering and processing of natural gas. It …
  • Kimball International, Inc. (KBAL)：企業の財務・戦略的SWOT分析
    Kimball International, Inc. (KBAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Clementia Pharmaceuticals Inc (CMTA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Clementia Pharmaceuticals Inc (Clementia) is a clinical stage biopharmaceutical company that focuses on the development of treatments for rare bone disorders and other diseases. Its lead product candidate Palovarotene is used for the treatment of fibrodysplasia ossificans progressiva (FOP), …
  • Beaver Aerospace & Defense, Inc.：企業の戦略・SWOT・財務情報
    Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CRH Medical Corp (CRH)：医療機器：M&Aディール及び事業提携情報
    Summary CRH Medical Corp (CRH Medical), formerly Medsurge Medical Products Corp, is a medical device company that offers treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It offers topical ointments and creams including preparation H …
  • Syngen Biotech Co Ltd (8279)-製薬・医療分野：企業M&A・提携分析
    Summary Syngen Biotech Co Ltd (Syngen), a part of Standard Chem& Pharm Co Ltd, is a biotechnology company that specializes in strain identification, micro-organism fermentation, recovery, and purification. The company research, develops, manufactures and distributes active pharmaceutical ingredients …
  • Pharnext SA (ALPHA)：企業の財務・戦略的SWOT分析
    Summary Pharnext SA (Pharnext), formerly Pharnext SAS is a biopharmaceutical company that develops novel therapies for severe neurodegenerative diseases. The company offers pleotherapy, a proprietary research and development platform based on network pharmacology that uses wide genomic data to ident …
  • PharmaCyte Biotech Inc (PMCB)-製薬・医療分野：企業M&A・提携分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company’s technology is used for the treatment of advanced and inoperable pancreatic cancer, and diabetes. It develops …
  • Bc Hydro
    Bc Hydro - Strategy, SWOT and Corporate Finance Report Summary Bc Hydro - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Cedar Fair, L.P.：企業の戦略・SWOT・財務情報
    Cedar Fair, L.P. - Strategy, SWOT and Corporate Finance Report Summary Cedar Fair, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Lee Memorial Health System：企業の戦略的SWOT分析
    Lee Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆